Kobayashi Pharmaceutical

Basic Information

Stock Code: 4967
Industry: Chemicals
Category Detail: Daily Necessities & Household Products
Prefecture: Osaka Prefecture
Establishment Year: August 1919
Listing Year: April 1999
Official Website: https://www.kobayashi.co.jp/
TSE Information: TSE Information
Yahoo! Finance: Yahoo! Finance
Other Companies: Glico, Kao, Shiseido, Lion, I-ne, Earth Corporation

Overview

Kobayashi Pharmaceutical is a Japanese chemical and pharmaceutical manufacturer founded in 1919, known as the domestic leader in hygiene products and air fresheners.

Current Situation

Kobayashi Pharmaceutical recorded consolidated sales of approximately 173.5 billion yen and net profit of 20.3 billion yen in 2023, maintaining a solid financial base. It holds high market share in its mainstay air freshener and hygiene materials businesses and is actively expanding into pharmaceuticals and health foods. The company has multiple subsidiaries domestically and internationally, aiming for business expansion in Asia and North America. In 2024, following health issues with its red yeast rice supplements, it temporarily suspended TV commercials and canceled its entry ceremony, undertaking corporate reforms. In product development, it leads the market with agile product planning and unique naming. Long-term challenges include sustainable product development and global expansion. In 2025, it will welcome its first president from outside the founding family, transitioning to a new corporate culture.

Trivia

Interesting Facts

Products feature unique and approachable naming
Over 100 years as a historic Japanese pharmaceutical company
Shouchu Moto and Bluelet certified by Guinness World Records
Subsidiary of disposable body warmer Kirihaze Chemistry to strengthen brand
High product recall frequency reflects strong product safety awareness
First non-founding family president appointed (2024)
Brand power enhanced by featuring numerous celebrities in TV commercials
Headquarters in historic Doshomachi, Chuo-ku, Osaka
Red yeast rice health food issue had major industry impact
Corporate slogan: 'Turning "It would be nice if" into reality'

Hidden Connections

Strategic relationships with multi-industry companies as part of Sanwa Group
Transactions with multiple competitors via OTC drug OEM production
Many advertising talents are prominent entertainers
Actively continues using brands from acquired subsidiaries
Headquarters location in Osaka's pharmaceutical cluster contributes to competitive advantage
Red yeast rice supplement incident prompting review of trademark management
Multi-channel sales structure to maximize product reach
Collaborations with medical institutions and contractors for clinical trials in product manufacturing

Future Outlook

Growth Drivers

Stable demand in domestic hygiene products market
Market expansion and consumer awareness of functional health foods
Overseas market channel expansion and brand penetration
Agile product development and speedy new product launches
Strengthened digital marketing and direct sales promotion
Enhanced development of sustainability-oriented products
Business efficiency through digital transformation
Investment in new business fields and diversification strategy
Improved customer service responsive to needs
Overcoming market entry barriers through regulatory compliance
Brand image recovery and enhanced social trust
Building sustainable management foundation

Strategic Goals

Expand sustainable products to 70% ratio while reducing environmental impact
Achieve over 40% overseas sales ratio
Expand functional labeled food sales to cumulative 50 billion yen
Achieve over 20% sales composition from new businesses
Strengthen marketing investment for brand value enhancement
Promote innovation in health and welfare fields
Promote digitalization and diversify customer touchpoints
Further strengthen corporate governance
Thorough product safety management and risk management enhancement
Promote diverse talent utilization and diversity

Business Segments

Pharmaceutical Manufacturing and Sales

Overview

Engages in OEM and own-brand manufacturing and sales centered on pharmaceuticals and quasi-drugs.

Competitiveness

Agile product development capabilities

Customers

Medical Institutions
Pharmacies
Drugstore Chains
Health Food Distributors

Products

Over-the-Counter Drugs
Quasi-Drugs
Pharmacy Drugs

Household Goods Manufacturing

Overview

Expanding market share through manufacturing and sales of high-function air fresheners and hygiene products.

Competitiveness

Unique brand naming and planning capabilities

Customers

Retailers
Supermarkets
Mail Order Companies
Specialty Stores

Products

Air Fresheners
Hygiene Sundries
Disposable Body Warmers

Health Food Manufacturing and Sales

Overview

Aiming for growth in manufacturing and sales of health foods and functional foods.

Competitiveness

Strict quality control and safety assurance

Customers

Health Food Wholesalers
Mail Order Companies
Drugstores
EC Site Operators

Products

Functional Labeled Foods
Natural-Derived Health Beverages
Supplements

Overseas Business

Overview

Promoting sales expansion and brand penetration in Asia and North America markets.

Competitiveness

Technology and sales network for international expansion

Customers

Local Distributors
Exporters
Overseas Drugstores
Specialty Trading Companies

Products

Over-the-Counter Drugs
Hygiene Products
Health Foods

OEM & Technology Provision

Overview

Provides development support for other companies' products through OEM production and joint research.

Competitiveness

Flexible production system accommodating diversification

Customers

Other Pharmaceutical Manufacturers
Cosmetics Manufacturers
Health Food Manufacturers

Products

Pharmaceutical OEM
Cosmetics OEM
Product Development Support

Mail Order Business

Overview

Delivers products directly to customers through mail order.

Competitiveness

Sales channels responsive to customer needs

Customers

General Consumers
Elderly Market
Health-Conscious Segments

Products

Health Foods
Pharmaceuticals
Household Goods

Competitive Advantage

Strengths

Brand power from unique naming
Diversified product lineup
High product planning and agile development capabilities
Stable financial base
Nationwide sales channel network
Balance of tradition and innovation
High share in domestic hygiene sundries market
Expansion capabilities in overseas markets
Extensive subsidiary network
High-quality pharmaceuticals and health foods
Continuous mass media utilization
Strong customer base
Excellent product recall and quality management
Active M&A strategy
Long-term management by founding family

Competitive Advantages

Customer recognition through unique and approachable product naming strategy
Capture of top share in niche markets like disposable body warmers and air fresheners
High market responsiveness enabling speedy new product launches
Diversification and efficiency in manufacturing and sales via extensive subsidiaries
Introduction of local store search system
Strengthening of direct sales channels using mail order
Stable business foundation supported by sound finances
Risk diversification through multi-field business expansion
Advancement of global expansion via overseas subsidiaries
Enhanced brand image through powerful TV commercials
Advanced initiatives on environmental and social issues within the industry
Sustained investment in R&D
Customer responsiveness from broad product portfolio
Strengthened governance through president change
Strong cooperative relationships with major retail chains

Threats

Brand image decline due to red yeast rice supplement issue
Intense price competition from rivals
Increased product development costs from stricter regulations
Risk of market share loss from delays in new product development
Uncertainty in consumer spending due to economic fluctuations
Quality issues and heightened social scrutiny in health food market
Political and regulatory risks in overseas markets
Production delays from supply chain disruptions
Delays in responding to rapid technological changes
Cost increases from strengthened environmental regulations
Changes in consumer needs due to aging society
Intensified market competition from new entrants

Innovations

2023: Full Acquisition of U.S. Topical Anti-Inflammatory Analgesic Company

Overview: Acquired anti-inflammatory analgesic and cosmetics manufacturer to accelerate overseas business expansion.
Impact: Contributes to expansion of overseas sales network and technological enhancement

2024: Introduction of Proprietary Store Search System

Overview: Developed in-house as a manufacturer without its own retail stores to improve consumer convenience.
Impact: Improved customer satisfaction and sales promotion effects

2023: Enhanced Safety for Health Foods and Establishment of Electronic Reporting System

Overview: Built electronic reporting system in response to health incident, enabling rapid response.
Impact: Achieved advanced risk management

2021: Launch of Pharmacy Drug 'Irakuna'

Overview: Entered new market in gastrointestinal drugs with Japan's first switch OTC product.
Impact: Succeeded in diversifying product portfolio

2020: Launch of Category 1 Drug 'Esplain SARS-CoV-2 & Flu A+B'

Overview: Strengthened infection control with test kit detecting COVID and influenza simultaneously.
Impact: Opened new market for infection control products

Sustainability

Eco promotion through reduced environmental impact of product packaging
Participation in regional environmental conservation projects
Strengthened sustainable product development and quality assurance
Improvement of workplace environments domestically and internationally
Promotion of corporate activities based on social responsibility